Earnings Feed
Start Free
Home/Filings/4/0001178913-26-000016
4//SEC Filing

LIEBERMAN GERALD M 4

Accession 0001178913-26-000016

CIK 0001638097other
View on SEC.govCompany Profile

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 4:21 PM ET

Size

11.1 KB

Accession

0001178913-26-000016

Insider Transaction Report

Form 4
Period: 2026-01-01
Entera Bio Ltd.ENTX
LIEBERMAN GERALD M
Director
Transactions
  • Award

    Ordinary Shares, par value NIS 0.0000769 per share

    2026-01-01+38,294→ 338,454 total
  • Award

    Stock Option (right to buy)

    2026-01-01+33,505→ 33,505 total
    Exercise: $1.94Exp: 2036-01-01→ Ordinary Shares, par value NIS 0.0000769 per share (33,505 underlying)
Holdings

  • Ordinary Shares, par value NIS 0.0000769 per share

    (indirect: By Trust)
    6,200

  • Ordinary Shares, par value NIS 0.0000769 per share

    (indirect: By Trust)
    6,200

  • Ordinary Shares, par value NIS 0.0000769 per share

    (indirect: By Trust)
    6,200

  • Ordinary Shares, par value NIS 0.0000769 per share

    (indirect: By Trust)
    6,200
Footnotes (3)
  • [F1]The Board of Directors ("Board") of Entera Bio Ltd. (the "Company") awarded these shares to the Reporting Persons in lieu of the cash fees the Reported Person was entitled to for services rendered as a director of the Company for the 2025 fiscal year.
  • [F2]These shares are owned by a Trust of which the Reporting Person's grandchild is the beneficiary, and the Reporting Person's spouse is the Trustee. The Reporting Person disclaims beneficial ownership of the securities held by this trust, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  • [F3]These options represent the Board's annual grant of options to directors of the Company. The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2026.

Documents

1 file

Issuer

Entera Bio Ltd.

CIK 0001638097

→
Entity typeother

Related Parties

1
  • filerCIK 0001234346

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:21 PM ET
Size
11.1 KB
View on SEC.gov